Mednet Logo
HomePediatric Hematology/OncologyQuestion

What is your escalation strategy for chronic GvHD?

1
1 Answers
Mednet Member
Mednet Member
Hematology · Dana-Farber Cancer Institute

There are now several available options for steroid resistant cGVHD. The old standbys - ECP and rituxan are useful in about 30% of patients. Ibrutinib was the first new drug to get FDA approval. Unfortunately, I don't think the real-world experience is anywhere near as good as the trial (Chin et al....

Register or Sign In to see full answer